PD-1/PD-L1-checkpoint blockade therapy is generally thought to relieve tumor cell-mediated
suppression in the tumor microenvironment but PD-L1 is also expressed on non-tumor …

We found upregulation of expression of the microRNA miR-155 in primary effector and effector
memory CD8 + T cells, but low miR-155 expression in naive and central memory cells. …

In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

The failure of CD8+ T cells to respond to chronic infection has been termed “exhaustion” and
describes the condition in which CD8+ T cells exhibit reduced differentiation, proliferation, …

Given the key role CD8 + T cells play in controlling viral infection, strategies to enhance
these responses may have important clinical applications. We found that in vivo CD137 …

CD8+ T cells are a critical component of the adaptive immune response against infections
and tumors. A current paradigm in immunology is that naive CD8+ T cells require CD28 …

Why HIV-specific CD8 + T cells ultimately fail to clear or control HIV infection is not known.
We show here that HIV-specific CD8 + T cells exhibit increased sensitivity to CD95/Fas-…

Quantitative or qualitative differences in immunity may drive clinical severity in COVID-19.
Although longitudinal studies to record the course of immunological changes are ample, they …

HIV-specific CD8 + T cells are prone to undergo apoptosis, and this may affect their ability to
control HIV infection. Because CD8-mediated immune responses play a key role in …

The increasing risk of incidental exposure to nanomaterials has led to mounting concerns
regarding nanotoxicity. Zinc oxide nanoparticles (ZnO NPs) are produced in large quantities …